Skip to main content
Article thumbnail
Location of Repository

Exploration and modification of the skeletal muscle metabolic response to exercise in chronic obstructive pulmonary disease

By Lorraine Calvert

Abstract

No abstract available

Publisher: University of Leicester
Year: 2009
OAI identifier: oai:lra.le.ac.uk:2381/7408

Suggested articles

Citations

  1. (1996). A comparison between an outpatient hospital-based pulmonary rehabilitation program and a home-care pulmonary rehabilitation program in patients with COPD. A follow-up of 18 months.
  2. (2004). A longitudinal study on the ammonia threshold in junior cyclists.
  3. (1987). A measure of quality of life for clinical trials in chronic lung disease.
  4. (1991). A physical activity questionnaire for the elderly.
  5. (2001). A randomised controlled trial of four weeks versus seven weeks of pulmonary rehabilitation in chronic obstructive pulmonary disease.
  6. (1998). A short outpatient pulmonary rehabilitation programme: immediate and longer-term effects on exercise performance and quality of life.
  7. (1982). A short questionnaire for the measurement of habitual physical activity in epidemiological studies.
  8. (1992). Adaptation of mitochondrial ATP production in human skeletal muscle to endurance training and detraining.
  9. (1989). Adenine nucleotide degradation in human skeletal muscle during prolonged exercise.
  10. (2005). Adenine nucleotide loss in the skeletal muscles during exercise in chronic obstructive pulmonary disease.
  11. (1999). Aerobic and strength training in patients with chronic obstructive pulmonary disease.
  12. (1999). Altered expression of myosin heavy chain in the vastus lateralis muscle in patients with COPD.
  13. (1997). Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.
  14. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation.
  15. (1992). Ammonia and amino acid metabolism in human skeletal muscle during exercise.
  16. (1990). Ammonia metabolism during intense dynamic exercise and recovery in humans.
  17. (1983). Ammonia metabolism in exercise and fatigue: a review.
  18. (2002). Ammonia threshold--comparison to lactate threshold, correlation to other physiological parameters and response to training.
  19. (1996). Ammonia uptake in inactive muscles during exercise in humans.
  20. (1980). AMP deamination and IMP reamination in working skeletal muscle.
  21. (1990). Anaerobic energy production and O2 deficit-debt relationship during exhaustive exercise in humans.
  22. (1997). Anaerobic energy production in human skeletal muscle in intense contraction: a comparison of 31P magnetic resonance spectroscopy and biochemical techniques.
  23. (1973). Anaerobic threshold and respiratory gas exchange during exercise.
  24. (1990). Analysis of serial measurements in medical research.
  25. and early results of single versus bilateral lung transplantation for emphysema.
  26. (1985). Arterial oxygen desaturation during treadmill and bicycle exercise in patients with chronic obstructive airways disease.
  27. (1985). Assessment of fatfree mass using bioelectrical impedance measurements of the human body.
  28. (2004). Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis.
  29. (2002). Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD.
  30. (1997). Biochemistry of Exercise and Training.
  31. (1984). Blood lactate and ammonium ion accumulation during graded exercise in humans.
  32. (1991). Body composition and exercise performance in patients with chronic obstructive pulmonary disease.
  33. (2005). Body composition and mortality in chronic obstructive pulmonary disease.
  34. (1991). Body composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease.
  35. (1989). Body Weight in Chronic Obstructive Pulmonary Disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. American Review of Respiratory Diseases
  36. (1994). Breathlessness in patients with chronic airflow limitation. Mechanisms and management.
  37. (1997). BTS Guidelines for the Management of Chronic Obstructive Pulmonary Disease. Thorax 52 (Suppl. 5) British Thoracic Society Standards of Care Subcommittee on Pulmonary Rehabilitation.
  38. (2003). Catabolic/anabolic balance and muscle wasting in patients with COPD.
  39. (1997). Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease.
  40. (1983). Changes in blood ammonia, lactate and amino acids in relation to workload during bicycle ergometer exercise in man.
  41. (1993). Changes in skeletal muscle with aging: effects of exercise training.
  42. (1998). Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle.
  43. (2004). Comment on the comparison of test-retest reliabilities for 2-day and 2-week intervals.
  44. (2000). Comparison of effects of supervised versus self-monitored training programmes in patients with chronic obstructive pulmonary disease.
  45. (1994). Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation.
  46. (1995). Comparison of peak oxygen consumption during cycle and treadmill exercise in severe chronic obstructive pulmonary disease.
  47. (2003). Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease.
  48. Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children.
  49. (1994). Corticosteroids contribute to muscle weakness in chronic airflow obstruction.
  50. Cytochrome Oxidase Activity and Mitochondrial Gene Expression in Skeletal Muscle of Patients with Chronic Obstructive Pulmonary Disease.
  51. (1994). Determining a minimal important change in a disease-specific Quality of Life Questionnaire.
  52. (2001). Development of a self-reported Chronic Respiratory Questionnaire (CRQ- SR).
  53. (1992). Development of a shuttle walking test of disability in patients with chronic airways obstruction.
  54. (2006). Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial.
  55. (1983). Effect of attitudes and beliefs on exercise tolerance in chronic bronchitis.
  56. (1997). Effect of endurance training on ammonia and amino acid metabolism in humans.
  57. (2004). Effect of exercise mode on oxygen uptake and blood gases in COPD patients.
  58. (1981). Effect of exercise on protein turnover in man.
  59. (1989). Effect of nutritional status on exercise performance in patients with chronic obstructive pulmonary disease.
  60. (2001). Effect of pulmonary rehabilitation on quadriceps fatiguability during exercise.
  61. (1993). Effect of temperature, duration of storage and sampling procedure on ammonia concentration in equine blood plasma.
  62. (1999). Effects of dichloroacetate infusion on human skeletal muscle metabolism at the onset of exercise.
  63. (1999). Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease.
  64. (2000). Effects of prolonged hypobaric hypoxia on human skeletal muscle function and electromyographic events.
  65. (1995). Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease.
  66. (2003). Efficacy of dichloroacetate as a lactate-lowering drug.
  67. (1998). Elevated inosine monophosphate levels in resting muscle of patients with stable chronic obstructive pulmonary disease.
  68. (1987). Endurance training reduces the magnitude of exerciseinduced hyperammonemia in humans.
  69. (1983). Energy metabolism and contraction force of human skeletal muscle in situ during electrical stimulation.
  70. (1998). Energy supply and muscle fatigue in humans.
  71. (1982). Energy-rich phosphagens, electrolytes and free amino acids in leg skeletal muscle of patients with chronic obstructive lung disease.
  72. (2008). Enhanced exercise performance in COPD using Dichloroacetate: A pharmacological intervention targeting skeletal muscle Eur Respir J.
  73. (2007). ERJ 2006;28 (suppl 50): A3573
  74. (1996). Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease.
  75. (2002). Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients.
  76. (1989). Exercise alters the distribution of ammonia and lactate in blood.
  77. (1992). Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation [see comments].
  78. (2001). Exercise in chronic pulmonary disease: limitations and rehabilitation.
  79. (1993). Exercise performance after lung transplantation.
  80. (2003). Exercise physiology in COPD.
  81. (2001). Exercise Testing and Interpretation. A Practical Approach.
  82. (1990). Exercise-induced hyperammonemia: peripheral and central effects.
  83. Exercise-induced lactate increase in relation to muscle substrates in patients with chronic obstructive pulmonary disease.
  84. (1998). Faster adjustment of O2 delivery does not affect V(O2) on-kinetics in isolated in situ canine muscle.
  85. (1985). First-order kinetics of muscle oxygen consumption, and an equivalent proportionality between QO2 and phosphorylcreatine level. Implications for the control of respiration.
  86. (1999). Folgering HT, Gimeno A & Dekhuijzen PN.
  87. (2004). for Chronic Conditions.
  88. (1989). Formation of inosine monophosphate (IMP) in human skeletal muscle during incremental dynamic exercise.
  89. (2002). Free radicals in the physiological control of cell function.
  90. (2005). From muscle disuse to myopathy in COPD: potential contribution of oxidative stress.
  91. (2007). Global Initiative for Chronic Obstructive Lung Disease.
  92. (2007). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
  93. (1974). Glycogen, glycolytic intermediates and high-energy phosphates determined in biopsy samples of musculus quadriceps femoris of man at rest. Methods and variance of values.
  94. (1994). Guidelines for the measurement of respiratory function.
  95. (1990). High-intensity strength training in nonagenarians. Effects on skeletal muscle.
  96. (2007). How long should a course of rehabilitation be?
  97. (2006). How long should outpatient pulmonary rehabilitation be? A randomised controlled trial of 4 weeks versus 7 weeks.
  98. (1989). Hypoxaemia increases the accumulation of inosine monophosphate (IMP) in human skeletal muscle during submaximal exercise.
  99. (1998). Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients.
  100. (1986). Importance of purine nucleotide cycle to energy production in skeletal muscle.
  101. Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate.
  102. (1996). Increased acetyl group availability enhances contractile function of canine skeletal muscle during ischemia.
  103. (2001). Inflammatory response and body composition in chronic obstructive pulmonary disease.
  104. (1985). Influence of aerobic metabolism on IMP accumulation in fast-twitch muscle.
  105. (1993). Influence of oral creatine supplementation of muscle torque during repeated bouts of maximal voluntary exercise in man.
  106. (1993). Influence of sodium bicarbonate ingestion on plasma ammonia accumulation during incremental exercise in man.
  107. (1994). Influence of sprint training on human skeletal muscle purine nucleotide metabolism.
  108. (1984). Influences of specimen processing and storage conditions on results for plasma ammonia.
  109. (1992). Inspiratory muscle training combined with general exercise reconditioning in patients with COPD.
  110. (1997). Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease.
  111. (1999). Interaction of factors determining oxygen uptake at the onset of exercise.
  112. (2003). Invited review: Aging and sarcopenia.
  113. (2001). Large energetic adaptations of elderly muscle to resistance and endurance training.
  114. (1995). Long-term oxygen therapy may improve skeletal muscle metabolism in advanced chronic obstructive pulmonary disease patients with chronic hypoxaemia.
  115. (1993). Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.
  116. (1971). Mechanism of adenosine triphosphate hydrolysis by actomyosin.
  117. (1986). Mechanisms and patterns of blood lactate increase during exercise in man.
  118. (1984). Mechanisms of blood lactate increase during exercise.
  119. Metabolic and hemodynamic responses of lower limb during exercise in patients with COPD.
  120. (1995). Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease [see comments].
  121. (1992). Metabolic factors in fatigue.
  122. (2004). Metabolic inertia in contracting skeletal muscle: a novel approach for pharmacological intervention in peripheral vascular disease.
  123. (1997). Metabolic responses from rest to steady state determine contractile function in ischemic skeletal muscle.
  124. (1996). Metabolic responses of canine gracilis muscle during contraction with partial ischemia.
  125. (1992). Metabolism and aerobic capacity of skeletal muscle in chronic respiratory failure related to chronic obstructive pulmonary disease.
  126. (2002). Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease.
  127. (2003). Milestones in human physiology: Muscle energy metabolism and blood flow during contraction.
  128. (2008). Minimum clinically important improvement for the incremental shuttle walking test.
  129. Modulation of ATP production by oxygen in obstructive lung disease as assessed by 31P-MRS.
  130. (1990). Morphological adaptations of human skeletal muscle to chronic hypoxia.
  131. morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease.
  132. (1998). Muscle acetyl group availability is a major determinant of oxygen deficit in humans during submaximal exercise.
  133. (1986). Muscle ammonia and amino acid metabolism during dynamic exercise in man.
  134. (1987). Muscle and blood ammonia and lactate responses to prolonged exercise with hyperoxia.
  135. (1991). Muscle ATP loss and lactate accumulation at different work intensities in the exercising Thoroughbred horse.
  136. (1995). Muscle energy metabolism and nutritional status in patients with chronic obstructive pulmonary disease. A 31P magnetic resonance study.
  137. (1983). Muscle fiber composition and blood ammonia levels after intense exercise in humans.
  138. (2003). muscle morphology, metabolism and muscle function:general principles. european respiratory monograph
  139. muscle morphometry, and blood lactate in chronic obstructive pulmonary disease.
  140. (1995). Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders.
  141. (1957). Muscle structure and theories of contraction.
  142. (1997). Muscle weakness is related to utilization of health care resources in COPD patients.
  143. (1990). Muscular atrophy following immobilisation. A review.
  144. (1994). Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in outpatients with COPD.
  145. (1997). Oxidation of urate in human skeletal muscle during exercise.
  146. (2000). Oxidative capacity and ageing in human muscle.
  147. (1996). Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD.
  148. (2000). Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD.
  149. (2002). Oxygen uptake on-kinetics in dog gastrocnemius in situ following activation of pyruvate dehydrogenase by dichloroacetate.
  150. (1997). Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease.
  151. (1975). Percutaneous needle biopsy of skeletal muscle in physiological and clinical research.
  152. (1989). Peripheral effects of endurance training in young and old subjects.
  153. (2000). Peripheral muscle dysfunction in chronic obstructive pulmonary disease.
  154. (2004). Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD.
  155. (2004). Peripheral muscle strength training in COPD: a systematic review.
  156. (1996). Peripheral muscle weakness contributes to exercise limitation in COPD.
  157. (1998). Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.
  158. (1998). Peripheral O2 diffusion does not affect V(O2)on-kinetics in isolated insitu canine muscle.
  159. (1998). Peripheral skeletal muscles and exercise performance in patients with chronic obstructive pulmonary disease.
  160. (1977). Physical rehabilitation for the chronic bronchitic: results of a controlled trial of exercises in the home.
  161. Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease.
  162. (1999). Physiological response to moderate exercise workloads in a pulmonary rehabilitation program in patients with varying degrees of airflow obstruction.
  163. (1991). Plasma and muscle amino acid and ammonia responses during prolonged exercise in humans.
  164. (1998). Plasma and muscle amino acid levels in relation to resting energy expenditure and inflammation in stable chronic obstructive pulmonary disease.
  165. (1992). Portable liquid oxygen and exercise ability in severe respiratory disability.
  166. (1991). Practical Statistics for Medical Research.
  167. (1993). Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation.
  168. (1982). Psychophysical bases of perceived exertion.
  169. (0037). Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev
  170. (1998). Pyruvate dehydrogenase complex activation status and acetyl group availability as a site of interchange between anaerobic and oxidative metabolism during intense exercise.
  171. (1996). Quadriceps strength and fatigue assessed by magnetic stimulation of the femoral nerve in man.
  172. (2007). Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease.
  173. (2001). Randomised Controlled Trial of Dietary Creatine as an Adjunct Therapy to Physical Training in COPD.
  174. Randomised controlled trial of respiratory rehabilitation [see comments].
  175. (1992). Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation.
  176. (2007). Recommendations on the use of exercise testing in clinical practice.
  177. (1991). Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease.
  178. (2006). Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study.
  179. (1993). Relationship between the lactate and ventilatory thresholds during prolonged exercise.
  180. (2002). Resistance versus endurance training in patients with COPD and peripheral muscle weakness.
  181. (1991). Resting energy expenditure in patients with chronic obstructive pulmonary disease.
  182. (2000). Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial.
  183. (1999). Role of pyruvate dehydrogenase in lactate production in exercising human skeletal muscle.
  184. (1992). Salbutamol, a beta 2-adrenoceptor agonist, increases skeletal muscle strength in young men [published erratum appears
  185. (1997). Sarcopenia and physical performance in old age: overview. Muscle Nerve Suppl 5:S5-S9.
  186. (2003). Signalling pathways that mediate skeletal muscle hypertrophy and atrophy.
  187. (1985). Single-run high-performance liquid chromatography of nucleotides, nucleosides, and major purine bases and its application to different tissue extracts.
  188. (1996). Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease.
  189. (2001). Skeletal muscle dysfunction in chronic obstructive pulmonary disease.
  190. (1999). Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society.
  191. (1987). Skeletal muscle energetics, acid-base equilibrium and lactate metabolism in patients with severe hypercapnia and hypoxemia.
  192. (1991). Skeletal muscle energy metabolism and fatigue during intense exercise in man.
  193. (2000). Skeletal muscle function in COPD.
  194. (1990). Skeletal muscle metabolites and fibre types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure.
  195. (2004). Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.
  196. (1986). Statistical methods for assessing agreement between two methods of clinical measurement.
  197. (1980). Statistics and ethics in medical research: III How large a sample?
  198. (1991). Statistics in respiratory medicine. 2. Repeatability and method comparison.
  199. (1988). Strength conditioning in older men: skeletal muscle hypertrophy and improved function.
  200. (1998). Substrate availability limits human skeletal muscle oxidative ATP regeneration at the onset of ischemic exercise.
  201. (2003). Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease.
  202. (1959). Terminology, definition and classification of chronic pulmonary emphysema and related conditions.
  203. (2002). The acetyl group deficit at the onset of contraction in ischaemic canine skeletal muscle.
  204. (1983). The ageing muscle.
  205. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.
  206. (2006). The burden of lung disease.
  207. (1998). The cardiorespiratory response to submaximal exercise in subjects with asthma following pretreatment with controlled release oral salbutamol and high-dose inhaled salmeterol.
  208. (2000). The challenge of providing better care for patients with chronic obstructive pulmonary disease: the poor re;ation of airways obstruction?
  209. (2005). The contribution of peripheral muscle function to shuttle walking performance in patients with chronic obstructive pulmonary disease.
  210. (2002). The contribution of starvation, deconditioning and ageing to the observed alterations in peripheral skeletal muscle in chronic organ diseases.
  211. (1924). The effect of fatigue on the relation between work and speed, in contraction of human arm muscles.
  212. (1992). The effect of salbutamol on performance in elite nonasthmatic athletes.
  213. (1999). The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease.
  214. (1968). The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers.
  215. (1999). The importance of pyruvate availability to PDC activation and anaplerosis in human skeletal muscle.
  216. (1991). The influence of dietary manipulation on plasma ammonia accumulation during incremental exercise in man.
  217. (2008). The major limitation to exercise performance in COPD is lower limb muscle dysfunction.
  218. (2003). The Nutritional Enhancement of Exercise Performance in Chronic Obstructive Pulmonary Disease. A Randomised Controlled Trial.
  219. (1989). The pharmacology of dichloroacetate.
  220. (1977). The purine nucleotide cycle. Studies of ammonia production by skeletal muscle in situ and in perfused preparations.
  221. (1985). The relationship between lactate and ventilatory thresholds: coincidental or cause and effect?
  222. (2000). Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease.
  223. (1994). Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease.
  224. (2000). Ventilatory and metabolic adaptations to walking and cycling in patients with COPD.
  225. (1998). Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease.
  226. Wouters underlying mechanisms and therapy perspectives.
  227. (1997). Xanthine oxidase in human skeletal muscle following eccentric exercise: a role in inflammation.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.